233 related articles for article (PubMed ID: 21850367)
1. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
Tozawa K; Sagawa M; Kizaki M
Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosis.
Ni H; Zhao W; Kong X; Li H; Ouyang J
PLoS One; 2014; 9(4):e95846. PubMed ID: 24755677
[TBL] [Abstract][Full Text] [Related]
3. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
Sethi G; Ahn KS; Pandey MK; Aggarwal BB
Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
[TBL] [Abstract][Full Text] [Related]
4. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
Sha M; Ye J; Zhang LX; Luan ZY; Chen YB; Huang JX
Pharmacology; 2014; 93(1-2):39-46. PubMed ID: 24434352
[TBL] [Abstract][Full Text] [Related]
5. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
[TBL] [Abstract][Full Text] [Related]
6. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
[TBL] [Abstract][Full Text] [Related]
7. Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation.
Ni H; Zhao W; Kong X; Li H; Ouyang J
Acta Haematol; 2014; 131(2):102-11. PubMed ID: 24157922
[TBL] [Abstract][Full Text] [Related]
8. TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.
Sagawa M; Tabayashi T; Kimura Y; Tomikawa T; Nemoto-Anan T; Watanabe R; Tokuhira M; Ri M; Hashimoto Y; Iida S; Kizaki M
Cancer Sci; 2015 Apr; 106(4):438-46. PubMed ID: 25613668
[TBL] [Abstract][Full Text] [Related]
9. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function.
Yu X; Meng X; Xu M; Zhang X; Zhang Y; Ding G; Huang S; Zhang A; Jia Z
EBioMedicine; 2018 Oct; 36():266-280. PubMed ID: 30268831
[TBL] [Abstract][Full Text] [Related]
10. Platycodin D inhibits proliferation, migration and induces chemosensitization through inactivation of the NF-κB and JAK2/STAT3 pathways in multiple myeloma cells.
Wu D; Zhang W; Chen Y; Ma H; Wang M
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1194-1200. PubMed ID: 31347196
[TBL] [Abstract][Full Text] [Related]
11. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
12. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
Wang Y; Zhang XL; Sun CM
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
[TBL] [Abstract][Full Text] [Related]
13. ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF-κB in multiple myeloma.
Jiang J; Sun Y; Xu J; Xu T; Xu Z; Liu P
Cancer Med; 2020 Oct; 9(19):7244-7252. PubMed ID: 32780537
[TBL] [Abstract][Full Text] [Related]
14. Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity.
Zhong YL; Xu GJ; Huang S; Zhao L; Zeng Y; Xiao XF; An JL; Liu J; Yang T
Eur J Pharmacol; 2019 Jun; 853():184-192. PubMed ID: 30928629
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity.
Que W; Chen J; Chuang M; Jiang D
APMIS; 2012 Mar; 120(3):195-203. PubMed ID: 22339676
[TBL] [Abstract][Full Text] [Related]
16. Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway.
Yang L; Chen J; Han X; Zhang E; Huang X; Guo X; Chen Q; Wu W; Zheng G; He D; Zhao Y; Yang Y; He J; Cai Z
Protein Cell; 2018 Sep; 9(9):770-784. PubMed ID: 29441489
[TBL] [Abstract][Full Text] [Related]
17. Effects of celastrol on enhancing apoptosis of ovarian cancer cells via the downregulation of microRNA‑21 and the suppression of the PI3K/Akt‑NF‑κB signaling pathway in an in vitro model of ovarian carcinoma.
Zhang H; Li J; Li G; Wang S
Mol Med Rep; 2016 Dec; 14(6):5363-5368. PubMed ID: 27840916
[TBL] [Abstract][Full Text] [Related]
18. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma.
He D; Xu Q; Yan M; Zhang P; Zhou X; Zhang Z; Duan W; Zhong L; Ye D; Chen W
BMC Cancer; 2009 Sep; 9():343. PubMed ID: 19778460
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
Du HF; Yu LJ; Meng YF; Lv HY; Meng J; Song XN; Zhang JQ
Leuk Lymphoma; 2013 Mar; 54(3):607-18. PubMed ID: 22889356
[TBL] [Abstract][Full Text] [Related]
20. KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway.
Song IS; Jeong YJ; Nyamaa B; Jeong SH; Kim HK; Kim N; Ko KS; Rhee BD; Han J
BMB Rep; 2015 Oct; 48(10):571-6. PubMed ID: 25772758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]